About
Exogene develops an AI-driven platform that uses deep learning to discover novel T-cell receptors for TCR-based therapies aimed at targeting solid tumors in cancer treatment.
Explore Exogene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.